Nitrate and Exercise-induced Cardiac Troponin T in Type 2 Diabetes
NCT ID: NCT01714674
Last Updated: 2012-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2012-10-31
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that dietary nitrate supplementation blunts the rise in cTnT levels following exercise in type 2 diabetic patients.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo beverage
the impact of placebo (no active substance) on exercise-induced cTnT release
NaCl beverage
ingestion of single dose NaCl beverage two hours prior to exercise bout
Dietary nitrate beverage
The impact of dietary nitrate (active substance) on exercise-induced cTnT release
Dietary nitrate beverage
ingestion of single dose NaNO3 beverage two hours prior to exercise bout
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary nitrate beverage
ingestion of single dose NaNO3 beverage two hours prior to exercise bout
NaCl beverage
ingestion of single dose NaCl beverage two hours prior to exercise bout
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* morbid obesity (BMI\>35 kg/m2)
* incident cardiovascular events in the last year (heart attack, stroke
* use medication which contain nitrates and/or having vasodilatory effects
40 Years
80 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luc van Loon, PhD
Role: PRINCIPAL_INVESTIGATOR
Maastricht UMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht UMC
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
research unit
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
METC 12-3-033
Identifier Type: -
Identifier Source: org_study_id
NL41071.068.12
Identifier Type: OTHER
Identifier Source: secondary_id